Last $112.61 USD
Change Today +1.54 / 1.39%
Volume 3.3M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
NASDAQ GM
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Graham Burton M.D., Ph.D., MBBS, FRCP

Former Senior Vice President of Global Regulatory Affairs, Pharmacovigilance, Corporate Quality and Compliance, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

63--

Background*

Dr. Graham Burton M.D., Ph.D., MBBS, FRCP served as Senior Vice President of Global Regulatory Affairs, Pharmacovigilence and Project Management of Celgene Corp. from July 8, 2003 to September 1, 2012. Dr. Burton's responsibility is to foster strong relationships with Global Regulatory agencies and manage the Celgene Drug Safety Pharmacovigilence Worldwide department. He also serves as a member of Celgene Corp.'s Senior Management Team. Dr. Burton joined Celgene with ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $112.61 USD +1.54

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Flemming Ornskov M.D., MBA, MPHManaging Director, Chief Executive Officer and Director
Shire plc
$2.7M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.